Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for SINT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 10.43M
March 31, 2026 7.811M
December 31, 2025 9.506M
September 30, 2025 11.36M
June 30, 2025 9.195M
March 31, 2025 11.45M
December 31, 2024 9.413M
September 30, 2024 11.30M
June 30, 2024 15.30M
March 31, 2024 17.56M
December 31, 2023 15.36M
September 30, 2023 15.51M
June 30, 2023 19.10M
March 31, 2023 22.65M
December 31, 2022 15.77M
September 30, 2022 14.56M
June 30, 2022 17.49M
March 31, 2022 18.88M
December 31, 2021 21.84M
September 30, 2021 24.87M
June 30, 2021 26.42M
March 31, 2021 28.68M
December 31, 2020 30.45M
September 30, 2020 32.63M
June 30, 2020 24.58M
Date Value
March 31, 2020 15.36M
December 31, 2019 9.147M
September 30, 2019 10.60M
June 30, 2019 11.28M
March 31, 2019 10.26M
December 31, 2018 11.52M
September 30, 2018 14.40M
June 30, 2018 22.61M
March 31, 2018 14.82M
December 31, 2017 14.64M
September 30, 2017 20.60M
June 30, 2017 22.65M
March 31, 2017 26.08M
December 31, 2016 26.26M
September 30, 2016 31.44M
June 30, 2016 27.50M
March 31, 2016 31.08M
December 31, 2015 36.45M
September 30, 2015 37.19M
June 30, 2015 39.97M
March 31, 2015 43.66M
December 31, 2014 47.58M
September 30, 2014 42.35M
June 30, 2014 43.33M
March 31, 2014 43.85M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ClearPoint Neuro, Inc. 86.74M
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M

Total Assets (Quarterly) Related Metrics